Literature DB >> 28799067

MiR-448 promotes vascular smooth muscle cell proliferation and migration in through directly targeting MEF2C.

Ruihong Zhang1, Li Sui2, Xiaojian Hong1, Mao Yang3, Weimin Li4.   

Abstract

Abnormal proliferation and migration of vascular smooth muscle cells (VSMCs) is a critical process in various cardiovascular diseases such as coronary artery disease (CAD), atherosclerosis, stroke, and hypertension. MicroRNAs (miRNAs) are small, short, and noncoding RNAs that inhibit gene expression through binding to the 3'-UTR (3' untranslated regions) of target gene mRNAs. We showed that the expression of miR-448 was upregulated in VSMCs from coronary atherosclerotic plaques compared with normal coronary artery tissues. We also found that PDGF-bb promoted VSMCs proliferation and could induce miR-448 expression. Ectopic miR-448 expression induced VSMCs proliferation. Overexpression of miR-448 induced ki-67 mRNA and protein expression. Moreover, we identified MEF2C was a direct target of miR-448 in VSMCs. Overexpression of miR-448 promoted VSMCs migration. Furthermore, overexpression of MEF2C decreased miR-448-induced VSMCs proliferation and migration. These evidences suggested that miR-448 played an important role in the proliferation and migration of VSMCs.

Entities:  

Keywords:  Cardiovascular disease; Environmental science; MEF2C; Vascular smooth muscle cells; miR-448; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28799067     DOI: 10.1007/s11356-017-9771-1

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  35 in total

1.  miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12.

Authors:  Y Lv; Y Lei; Y Hu; W Ding; C Zhang; C Fang
Journal:  Clin Transl Oncol       Date:  2015-06-24       Impact factor: 3.405

2.  Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long noncoding RNA MALAT1.

Authors:  Yonghua Han; Yuchen Liu; Hu Zhang; Tiantian Wang; Ruiying Diao; Zhimao Jiang; Yaoting Gui; Zhiming Cai
Journal:  FEBS Lett       Date:  2013-10-25       Impact factor: 4.124

3.  The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.

Authors:  Nakwon Choe; Jin-Sook Kwon; Ju-Ryoung Kim; Gwang Hyeon Eom; Yongsook Kim; Kwang-Il Nam; Youngkeun Ahn; Hae Jin Kee; Hyun Kook
Journal:  Atherosclerosis       Date:  2013-05-20       Impact factor: 5.162

4.  MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells.

Authors:  H Ohdaira; M Sekiguchi; K Miyata; K Yoshida
Journal:  Cell Prolif       Date:  2011-12-13       Impact factor: 6.831

Review 5.  MicroRNA expression and its clinical implications in Ewing's sarcoma.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; William Ka Kei Wu; Matthew T V Chan
Journal:  Cell Prolif       Date:  2014-12-22       Impact factor: 6.831

Review 6.  MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.

Authors:  Xin Yu; Zheng Li; Jun Yu; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-07-22       Impact factor: 6.831

7.  MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1.

Authors:  Pan Li; Yan Liu; Bing Yi; Guokun Wang; Xiaohua You; Xianxian Zhao; Ross Summer; Yongwen Qin; Jianxin Sun
Journal:  Cardiovasc Res       Date:  2013-04-03       Impact factor: 10.787

Review 8.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

Review 9.  The role of microRNAs expression in laryngeal cancer.

Authors:  Xin Yu; Zheng Li
Journal:  Oncotarget       Date:  2015-09-15

10.  Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation.

Authors:  George S Karagiannis; Jochen Weile; Gary D Bader; Joe Minta
Journal:  BMC Cardiovasc Disord       Date:  2013-01-16       Impact factor: 2.298

View more
  15 in total

1.  miR-365b-3p inhibits the cell proliferation and migration of human coronary artery smooth muscle cells by directly targeting ADAMTS1 in coronary atherosclerosis.

Authors:  Yunfei Qu; Ning Zhang
Journal:  Exp Ther Med       Date:  2018-09-11       Impact factor: 2.447

2.  MicroRNA-532-5p protects against atherosclerosis through inhibiting vascular smooth muscle cell proliferation and migration.

Authors:  Huijuan Sun; Shanshan Wu; Bin Sun
Journal:  Cardiovasc Diagn Ther       Date:  2020-06

Review 3.  Pathogenic role of microRNAs in atherosclerotic ischemic stroke: Implications for diagnosis and therapy.

Authors:  Qidi Jiang; Yiran Li; Quanli Wu; Li Huang; Jiasheng Xu; Qingfu Zeng
Journal:  Genes Dis       Date:  2021-01-12

4.  miR-3646 promotes vascular inflammation and augments vascular smooth muscle cell proliferation and migration in progression of coronary artery disease by directly targeting RHOH.

Authors:  Xiaoli Kang; Simin Cao; Zheng Ji; Yu Zhang; Shuxian Sun; Xiaoming Shang
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

5.  Differentially expressed mRNAs and their upstream miR-491-5p in patients with coronary atherosclerosis as well as the function of miR-491-5p in vascular smooth muscle cells.

Authors:  Hui Ding; Quanhua Pan; Long Qian; Chuanxian Hu
Journal:  Korean J Physiol Pharmacol       Date:  2022-05-01       Impact factor: 2.016

6.  Diagnostic value of miR-92a in asymptomatic carotid artery stenosis patients and its ability to predict cerebrovascular events.

Authors:  Gang Chen; Jianwei Gao; Yuguo Sheng; Xinqiang Han; Xingang Ji; Mengpeng Zhao; Jian Wu
Journal:  Diagn Pathol       Date:  2020-06-10       Impact factor: 2.644

Review 7.  MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction.

Authors:  Ji-Ru Zhang; Hai-Jian Sun
Journal:  Hypertens Res       Date:  2020-09-23       Impact factor: 3.872

8.  Relationship of cardiovascular disease risk factors and noncoding RNAs with hypertension: a case-control study.

Authors:  Shiying Chen; Rong Chen; Tingxing Zhang; Shaowei Lin; Zhou Chen; Bi Zhao; Huangyuan Li; Siying Wu
Journal:  BMC Cardiovasc Disord       Date:  2018-04-02       Impact factor: 2.298

9.  The MicroRNA-551a/MEF2C Axis Regulates the Survival and Sphere Formation of Cancer Cells in Response to 5-Fluorouracil.

Authors:  Hoin Kang; Chongtae Kim; Eunbyul Ji; Sojin Ahn; Myeongwoo Jung; Youlim Hong; WooK Kim; Eun Kyung Lee
Journal:  Mol Cells       Date:  2019-01-24       Impact factor: 5.034

10.  STAT1 and its related molecules as potential biomarkers in Mycobacterium tuberculosis infection.

Authors:  Xing-Hao Yi; Bo Zhang; Yu-Rong Fu; Zheng-Jun Yi
Journal:  J Cell Mol Med       Date:  2020-02-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.